Skip to main content
Equibles

Ikarian Capital, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1778253 DALLAS, TX
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$119,387
-$176,486 QoQ
Shares Held
519,077
0.0% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 48 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. VTGN ranks #99 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in VTGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,387 519,077
2026-03-31 $295,873 519,077
2025-12-31 $342,590 519,077
2025-09-30 $2,204,084 620,869
2025-06-30 $1,203,406 601,703
2025-03-31 $1,504,257 601,703
2024-12-31 $228,967 77,616
2023-09-30 $1,200,484 229,100
2022-03-31 $633,870 511,186
2021-12-31 $927,601 475,693
2021-09-30 $1,645,898 600,693
2021-06-30 $2,887,138 916,552
2021-03-31 $6,147,077 2,885,952
2020-12-31 $8,702,746 4,485,952